An approach that defines Focus Areas by combining not only disease areas but also disease causes, therapeutic modalities, and platform technologies, thereby narrowing the scope of R&D investment. By concentrating on priority areas, it aims to create value through achievements such as reaching clinical proof of concept (PoC) and advancing candidates into late-stage trials.